Zriza Specialities Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 6 Year, 5 Months
- Last Filing with ROC 31 Mar 2021
- Revenue Growth %
- Profit Growth -192.94%
- Net Worth -41.09%
- Total Assets 16.84%
About Zriza Specialities
Zriza Specialities Private Limited (ZSPL) is a Private Limited Indian Non-Government Company incorporated in India on 31 August 2018 (Six years and five months 0 days old ). Its registered office is in Bangaluru, Karnataka, India.
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Chethan Gangaiah and Anganna Amirtha serve as directors at the Company.
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24290KA2018PTC115907
- Company No.
115907
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
31 Aug 2018
- Date of AGM
30 Nov 2021
- Date of Balance Sheet
31 Mar 2021
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Who are the key members and board of directors at Zriza Specialities?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Chethan Gangaiah  | Director | 31-Aug-2018 | Current |
| Anganna Amirtha | Director | 31-Aug-2018 | Current |
Financial Performance of Zriza Specialities.
Zriza Specialities Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 192.94% decrease in profit. The company's net worth observed a substantial decline by a decrease of 41.09%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Zriza Specialities?
Unlock access to Zriza Specialities's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Zriza Pharmaceuticals Private LimitedChethan Gangaiah is a mutual person
Wavolution Laboratories Private LimitedChethan Gangaiah is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Zriza Specialities?
Unlock and access historical data on people associated with Zriza Specialities, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Zriza Specialities, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Zriza Specialities's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.